Efficacy of 2-methoxyethoxy-modified antisense oligonucleotides for the study of mouse preimplantation development

Reproductive BioMedicine Online

Volumn 6, Issue 3, 2003, Pages 318-322

  Kimber, Wendy L ^a   Puri, Nitin ^a   Borgmeyer, Carol ^a   Ritter, Donna ^a   Sharov, Alexei ^a   Seidman, Michael ^a   Ko, Minoru S H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antisense oligonucleotide; Embryo; Gene 'knockdown'; Preimplantation development

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA DETERMINATION; DNA MICROARRAY; DNA MODIFICATION; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE REPRESSION; MALE; MOUSE; NIDATION; NONHUMAN; STRUCTURE ANALYSIS;

EID: 0037899085     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61851-2     Document Type: Article

References (23)

1. Altmann KH, Fabbro D, Dean NM et al. 1996 Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors. Biochemical Society Transactions 24, 630-637.
2. Chen BB, Hales F 1995 Antisense oligonucleotide down-regulation of E-cadherin in the yolk sac and cranial neural tube malformations. Biology of Reproduction 53, 1229-1238.
3. Corey D, Abrams RJM 2001 Morpholino antisense oligonucleotides: tools for investigating vertebrate development. Genome Biology 2, 1015.
4. Dean NM 2001 Functional genomics and target validation approaches using antisense oligonucleotide technology. Current Opinion in Biotechnology 12, 622-625.
5. Eder PS, DeVine RJ, Dagle JM et al. 1991 Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma. Antisense Research and Development 1, 141-151.
6. Heasman J 2002 Morpholino oligos: making sense of antisense? Developmental Biology 243, 209-214.
7. Kemler R 1993 From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends in Genetics 9, 317-321.
8. Ko MS 2001 Embryogenomics: developmental biology meets genomics. Trends in Biotechnology 19, 511-518.
9. Ko MS, Kitchen JR, Wang X et al. 2000 Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development. Development 127, 1737-1749.
10. Lebedeva IC, Stein A 2001 Antisense oligonucleotides: promise and reality. Annual Review of Pharmacology and Toxicology 41, 403-419.
11. Martin P 1996 Stereoselective synthesis of 2′-O-(2-methoxyethyl)ribonucleosides: neighboring-group participation of the methoxyethoxy group in the ribosylation step. Helvetica Chimica Acta 79, 1930-1938.
12. Monia BP, Lesnik EA, Gonzalez C et al. 1993 Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. Journal of Biological Chemistry 268, 14514-14522.
13. Penberthy WT, Shafizadeh E, Lin S 2002 The zebrafish as a model for human disease. Frontiers in Bioscience 7, d1439-1453.
14. 2+ and relocation of E-cadherin during experimental decompaction of mouse embryos. Proceedings of the National Academy of Science of the USA 95, 12977-12982.
15. SAS Institute 1996 SAS/STAT software: changes and enhancements through release 6.11. SAS Institute, Cary, NC.
16. Solter D, de Vries WN, Evsikov AV et al. 2002 Fertilization and activation of the embryonic genome. In: Rossant J, Tam PPL (eds) Mouse Development. Patterning, Morphogenesis, and Organogenesis. Academic Press, London, pp. 5-19.
17. Stec WJ, Egan W, Stec B 1984 Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogues of oligodeoxyribonucleotides. Journal of the American Chemical Society 106, 6077-6080.
18. Stein CA, Cheng YC 1993 Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261, 1004-1012.
19. Summerton J, Weller D 1997 Morpholino antisense oligomers: design, preparation, and properties. Antisense and Nucleic Acid Drug Development 7, 187-195.
20. Svoboda P, Stein P, Hayashi H et al. 2000 Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 127, 4147-4156.
21. Takeichi M 1991 Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251, 1451-1455.
22. Tanaka T.S, Jaradat SA, Lim MK et al. 2000 Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proceedings of the National Academy of Sciences of the USA 97, 9127-9132.
23. Wianny F, Zernicka-Goetz M 2000 Specific interference with gene function by double-stranded RNA in early mouse development. Nature Cell Biology 2, 70-75.